Irina Petrache, MD, ATSF, elected in 2021, serves as the President.
Dr. Petrache is professor of medicine at National Jewish Health and at the University of Colorado. She also serves as chief of Pulmonary, Critical Care and Sleep Medicine, associate vice president of Faculty Development, and Wollowick Chair in COPD Research at National Jewish Health. Dr. Petrache joined the ATS in 1997 and is a member of the Respiratory Cell & Molecular Biology Assembly. 1
Raed A. Dweik, MD, MBA, ATSF, elected in 2023, serves as the President-Elect. Dr. Dweik will serve as President in 2025-2026.
Dr. Dweik currently holds the E. Tom and Erica Meyer Endowed Professorship and serves as chair of Pulmonary and Critical Care Medicine and enterprise chief of the Integrated Hospital Care Institute - IHI (Pulmonary, Critical Care, Infectious Disease, Emergency Services, Urgent and Express Care, Anesthesiology, Hospital Medicine, Perioperative Medicine) at Cleveland Clinic Health System. Dr. Dweik joined the ATS in 1994 and is a member of the Pulmonary Circulation Assembly. 2
Michelle Ng Gong, MD, MS, elected in 2024, serves as the Secretary. Dr. Gong will serve as President in 2026-2027.
Dr. Gong currently holds the position of professor and chief, Divisions of Pulmonary Medicine and of Critical Care Medicine, and director of Critical Care Research, Montefiore Medical Center and Albert Einstein College of Medicine. Dr. Gong joined the ATS in 1998 and is a member of the Critical Care Assembly. 3
M. Patricia Rivera, MD, ATSF, elected in 2020, serves as the Immediate Past- President.
Dr. Rivera is the C. Jane Davis & C. Robert Davis Distinguished Professor in Pulmonary Medicine, as well as chief, Division of Pulmonary and Critical Care Medicine at the University of Rochester Medical Center. She also serves as adjunct professor of Medicine at the University of North Carolina at Chapel Hill, and the co-director of the North Carolina Lung Screening Registry. Dr. Rivera originally founded the Multidisciplinary Lung Cancer Screening Program at UNC. Dr. Rivera joined the ATS in 1988 and is a member of the Thoracic Oncology Assembly. 4
Jesse Roman, MD, ATSF, elected in 2022, serves as the ATS Treasurer through 2025.
Dr. Roman is the Ludwig Kind Professor of Medicine and enterprise division chief, Pulmonary, Allergy and Critical Care Medicine. He also serves as CEO of the Jane & Leonard Korman Respiratory Institute of Jefferson Health and National Jewish Health. Dr. Roman conducts NIH-sponsored research in lung tissue remodeling and is involved in clinical trials. He joined the ATS in 1988 and is a member of the Respiratory Cell & Molecular Biology Assembly. 5
Karen J. Collishaw, MPP, CAE, appointed as Chief Executive Officer in May 2018.
Prior to joining the ATS, Ms. Collishaw was the president & CEO of the Community Health Accreditation Program, an independent, not-for-profit accrediting body for community-based health care organizations. Previously, Ms. Collishaw served in executive leadership positions with two professional medical societies--the American Academy of Dermatology and the American College of Cardiology. She was responsible for activities related to science, research, advocacy, quality, and managed the ACC’s annual scientific session.
Following the completion of a Bachelor of Arts in Government from Cornell University, Ms. Collishaw started her career working for the U.S. House of Representatives and then in Battelle Memorial Institute’s Washington office. She earned a Master of Public Policy degree from Georgetown University, is a certified association executive, and past president of the American Association of Medical Society Executives.
Observer:
Gregory Tino, MD, ATSF, FCCP, FACP, elected in 2024, serves as the ATS Treasurer-Elect; will serve as Treasurer, 2025-2028.
Dr. Tino is chief of the Medicine Department at Penn Presbyterian Medical Center and senior vice chair of the Medicine Department at Perelman School of Medicine, University of Pennsylvania. He joined the ATS in 1991 and is a member of the Clinical Problems Assembly. 6
- 2024 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Petrache is a scientific co-founder of Allinaire Therapeutics, which develops novel therapeutics for pulmonary arterial hypertension and other pulmonary diseases, including EMAP II. She conducted research supported by Allinaire, which evolved from her work with colleagues as part of the University of Indiana Center for Biomedical Innovation and is funded by Biomotiv. She also served as a consultant for Ceramedix for antibody therapies andparticipated in National Institutes of Health-supported research on sphingolipids and the effect of vaping on lung parenchyma. back to text
- 2024 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Dweik is an investigator and inventor on a Joint Development and Option agreement between the Cleveland Clinic and BreathTech Corporation, a wholly owned subsidiary of Astrotech Corporation. The aim of the research project is to develop a rapid breath test for coronavirus infection or related indicators. Dr. Dweik is entitled to commercialization revenues as an inventor of the intellectual property. back to text
- 2024 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Gong serves as a scientific advisor for hemodynamic monitoring and prediction for Philips. She serves on the data safety and monitoring board for Regeneron Pharmaceuticals focusing on monoclonal antibodies in COVID-19 trials. back to text
- 2024 Disclosure of Potential Conflicts of Interest Relevant to ATS Activities: Dr. Rivera conducts research supported by the National Institutes of Health focused on implementation and dissemination of lung cancer screening in real-world settings and comorbidity and functional status of persons undergoing lung cancer screening. She serves as a consultant for American Board of Internal Medicine for pulmonary boards writing committee. She serves as a consultant for the American Cancer Society. back to text
- 2024 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Roman received industry-sponsored research support to his institution for anti-fibrotic treatment from F. Hoffmann-LaRoche, Horizon Therapeutics, Galapagos, Syneos Health, Boehringer Ingelheim, Bellerophon Therapeutics. He served as a consultant for Boehringer Ingelheim, developing a national registry designed to obtain real-life data about interstitial lung disorders. He serves on the DSMB for an NIH-sponsored trial. back to text
- 2024 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Tino provided research support for the COPD Foundation on behalf of the University of Pennsylvania by serving as principal investigator for bronchiectasis and NTM research registry. back to text